JLHL (Mid Cap) Share Target 2024, 2025 To 2039
|
Jupiter Life Line Hospitals Limited |
|||
|
Price: ₹1,568.55 | ||
| 52 Week Low: ₹1,050.00 52 Week High: ₹1,653.95 |
|||
| Market Capital: 10,209.12 Crore (Midcap) | |||
| Healthcare -> Medical Care Facilities | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: JLHL Share Price Target For 2024
- 1.1.1: JLHL Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: JLHL Share Price Target For 2025
- 1.2.1: JLHL Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: JLHL Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: JLHL Brief Company Overview
- 4: JLHL Financial Performance
- 4.0.1: Is JLHL A Good Buy For Long Term?
To predict the JLHL's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
JLHL Share Price Target For 2024
The line chart displays the monthly closing prices of JLHL with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for JLHL shares in 2024, see the table below.
JLHL Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 1647.0 (+5%) | Fibonacci Extension Level 100.00% |
| 2024 Target 2 | 1618.75 (+3.2%) | Price Action: 10 Dec 2024 High |
| 2024 Target 1 | 1597.9 (+1.87%) | Price Action: 20 Dec 2024 High |
| Current Price | 1568.55 | JLHL's share price as of 23 Dec 2024 |
| Stop Loss 1 | 1556.55 (-0.77%) | Price Action: 22 Nov 2024 High |
| Stop Loss 2 | 1535.05 (-2.14%) | Price Action: 19 Dec 2024 Low |
| Stop Loss 3 | 1513.09 (-3.54%) | Price Action: 12 Nov 2024 Low |
Short-Term Technical Outlook
Current Technical Position: JLHL is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 25-day moving average at ₹1538.91 serves as the nearest technical reference point.
Historical Returns: 3-month: +11.31% | 6-month: +21.27% | 1-year: +44.44%
JLHL Share Price Target For 2025
The line chart displays the monthly closing prices of JLHL with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for JLHL shares in 2025, see the table below.
JLHL Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 2011.5 (+28.23%) | Price Action: Chart |
| 2025 Target 2 | 1973.99 (+25.84%) | Price Action: Chart |
| 2025 Target 1 | 1954.45 (+24.6%) | Fibonacci Extension Level 150.00% |
| Current Price | 1568.55 | JLHL's share price as of 23 Dec 2024 |
| Stop Loss 1 | 1477.0 (-5.84%) | Price Action: Dec 2024 Low |
| Stop Loss 2 | 1456.75 (-7.13%) | Technical Indicator: MA50 |
| Stop Loss 3 | 1434.19 (-8.57%) | Price Action: 08 Nov 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: JLHL is currently trading near its 52-week high of ₹1653.95, showing strong yearly momentum.
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +44.44% | 3-year: NA | 5-year: NA
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
JLHL Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹1,568.55 | ||
| 2024 | ₹1,517.56 | -3.25% | ₹1,540.32 |
| 2025 | ₹1,918.46 | +26.41% | ₹1,947.24 |
| 2026 | ₹2,354.64 | +22.73% | ₹2,389.96 |
| 2027 | ₹2,763.45 | +17.36% | ₹2,804.90 |
| 2028 | ₹3,179.52 | +15.05% | ₹3,227.21 |
| 2029 | ₹3,568.80 | +12.24% | ₹3,622.33 |
| 2030 | ₹3,959.74 | +10.95% | ₹4,019.14 |
| 2031 | ₹4,420.42 | +11.63% | ₹4,486.73 |
| 2032 | ₹4,826.00 | +9.17% | ₹4,914.46 |
| 2033 | ₹5,244.37 | +8.66% | ₹5,323.04 |
| 2034 | ₹5,620.04 | +7.16% | ₹5,704.34 |
| 2035 | ₹6,001.02 | +6.77% | ₹6,091.04 |
| 2036 | ₹6,486.20 | +8.08% | ₹6,583.49 |
| 2037 | ₹6,888.54 | +6.2% | ₹7,045.17 |
| 2038 | ₹7,309.22 | +6.1% | ₹7,418.86 |
| 2039 | ₹7,637.09 | +4.48% | ₹7,751.65 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
JLHL Brief Company Overview
Jupiter Life Line Hospitals Limited: A Leading Healthcare Provider in India Established in 2002, Jupiter Life Line Hospitals Limited is a multi-specialty hospital that offers a comprehensive range of healthcare services under the Jupiter brand throughout India. With a strong...
presence in Mumbai and Thane, Jupiter Life Line has earned a reputation for delivering high-quality medical care and exceptional patient experiences. The company's diverse product range encompasses a wide spectrum of specialties, including bariatric surgery, breast care, cardiac surgery, cardiology, dental care, dermatology, ENT, gastroenterology, general surgery, HPB, hematology, infectious diseases, interventional radiology, mental health, nephrology, neurology, neurosurgery, nutrition, obstetrics, oncology, ophthalmology, organ transplant, orthopedics, pediatrics, pain management, plastic surgery, rehabilitation, rheumatology, robotic knee replacement, and urology. Jupiter Life Line also operates specialized departments such as a breast care center, chest medicine clinic, and pain clinic. Jupiter Life Line Hospitals Limited is committed to providing accessible, affordable, and compassionate healthcare services to its patients. The company's team of highly skilled medical professionals and support staff are dedicated to ensuring that each patient receives personalized care and attention.JLHL Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 10,209.12 Crore | Market valuation of JLHL's shares. |
| Revenue (TTM) | 1,142.74 Crore | Total revenue generated by JLHL over the past twelve months. |
| Net Income (TTM) | +167.21 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +20.71% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +14.63% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+19% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-17.39% | Change in earnings compared to the same quarter last year. |
| Total Cash | 318.11 Crore | Total amount of liquid funds available to JLHL. |
Is JLHL A Good Buy For Long Term?
No valid response content found
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
